From our practice
Notes
Eucade’s own analysis of what wins, across all three routes. No client cases, no invented figures.
On the rise of cyber cascade
Why regulation, not hype, is driving cybersecurity cascade funding, and what that means for how you write.
Read note Open callsAI, Data & Smart IndustryEvidence beats novelty
In sectoral-AI calls, the panel has stopped believing "state of the art." Here is what it rewards instead.
Read note Open callsCleanTechImpact in the evaluators' language
The most common reason strong clean-tech applications lose points on impact, and the fix.
Read note Open callsAcross sectorsWhy applications fail before the technology is read
Two administrative things decide a cascade application before its technical merit is weighed. Both are inside your control.
Read note Open callsHealth & Life SciencesTwo health calls that everyone calls a grant, and neither is
EIT Health takes options over your equity before a single euro moves. Almost every summary of these calls leaves that out.
Read note Joint R&D TrackJoint transnational R&DEligibility decides before the science is read
Eurostars rejects on seven administrative criteria before an assessor reaches your technology. Four of them catch people who deserved to pass.
Read note Scale-up TrackDeeptech scale-upThe EIC decides in two places, and most preparation ignores the first
Roughly one in eight full applications reaches the interview. About half of those that do are funded. That asymmetry should decide how you prepare.
Read note